Search
Conduit Pharmaceuticals Inc
CDTAdd to Watchlist
0.494USD
-0.030-5.71%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
1.82KMarket Cap
LossP/E TTM
Conduit Pharmaceuticals Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-29.45K
52.19%
Analyst Rating
--
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What are the current assets of Conduit Pharmaceuticals Inc?
According to Conduit Pharmaceuticals Inc's FY2025 earnings report, its current assets were 4.38M, with a year-on-year change of 61.29.
What are the total assets of Conduit Pharmaceuticals Inc?
According to Conduit Pharmaceuticals Inc's FY2025 earnings report, its total assets of Conduit Pharmaceuticals Inc were 5.65M, with a year-on-year change of 34.75.
What are the total liabilities of Conduit Pharmaceuticals Inc?
According to Conduit Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Conduit Pharmaceuticals Inc were 12.82M, with a year-on-year change of 16.69.
What is the total equity of Conduit Pharmaceuticals Inc?
According to Conduit Pharmaceuticals Inc's FY2025 earnings report, its total equity of Conduit Pharmaceuticals Inc was -7.17M, with a year-on-year change of -5.55.
What is the net investment of Conduit Pharmaceuticals Inc?
According to Conduit Pharmaceuticals Inc's FY2025 earnings report, its net investment of Conduit Pharmaceuticals Inc was -808.00K, with a year-on-year change of -1779.07.
What is the net financing of Conduit Pharmaceuticals Inc?
According to Conduit Pharmaceuticals Inc's FY2025 earnings report, its net financing of Conduit Pharmaceuticals Inc was 17.42M, with a year-on-year change of 187.16.
What is the Earnings Per Share (EPS) of Conduit Pharmaceuticals Inc?
According to Conduit Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -29447.45, with a year-on-year change of 52.19.
What is the debt-to-asset ratio of Conduit Pharmaceuticals Inc?
According to Conduit Pharmaceuticals Inc's FY2025 earnings report, its debt-to-asset ratio was 11.68, with a year-on-year change of -93.23.
What is the Return on Assets (ROA) of Conduit Pharmaceuticals Inc?
According to Conduit Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -796.99, with a year-on-year change of -155.57.
What is the operating profit of Conduit Pharmaceuticals Inc?
According to Conduit Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -36.76M, with a year-on-year change of -138.39.